skip to content

Color has been recognized by Fast Company as a 2024 Next Big Things in Tech Award winner in the Health category. Learn more.

News & Articles

Introducing Robin Cole

Alicia Zhou

Robin Cole is an NFL legend. As a Pittsburgh Steelers linebacker from 1977–1987, he was part of the famous Steel Curtain defense that helped the team win four Super Bowls in six seasons. Robin himself is a two-time Super Bowl champion (XIII and XIV).

He’s also a prostate cancer survivor. I first met Robin at a urology retreat in Toronto. He sat across from me during a roundtable discussion on the importance of raising awareness for prostate cancer genetics among men. He was animated, passionate, and personal: I learned that he came from a big family of ten children total, eight boys. I learned that all eight of those boys, including Robin, had been diagnosed with prostate cancer. I learned that Robin’s father, Obediah, had passed away from prostate cancer. I learned that, despite all of this, prostate cancer remains a difficult subject to talk about for some of his brothers.

And of course, I learned that all of this is why Robin has become such a strong advocate for genetic testing and prostate cancer awareness. Robin’s non-profit foundation, the Robin Cole Foundation, promotes prostate cancer education, awareness, research and treatment. Through it, Robin shares his personal story, his family’s story, and educates the general public about the importance of genetic testing and regular screening for prostate cancer.

Robin Cole is a legend, a prostate cancer survivor, and an increasingly vocal health advocate. But most importantly to me, Robin Cole is my friend. So I’m honored and delighted to share this video that we worked on together to raise awareness for prostate cancer and genetic testing around the world.

Genomics

How 30,000 People Took More Control of Their Health: A Milestone in Accessible Personalized Medicine

Hairless woman portrait at home looking through the window with folded arms waiting for coffee.
Genomics

Too few cancer patients receive genetic testing—after they’ve been diagnosed